Skin Disease in Transplant Recipients and Immunosuppressed Patients

The session focused on skin diseases affecting transplant recipients and immunosuppressed patients, highlighting the increased risk of skin cancer and emphasizing management strategies. Sean Christensen, a surgeon from Yale University, provided an overview of the relationship between organ transplantation, immunosuppression, and skin cancer. He discussed the historical context of transplantation and advancements in immunosuppressive medications that have improved graft survival rates. A case study of a kidney transplant patient who developed multiple squamous cell carcinomas illustrated the complexities surrounding skin cancer in these individuals. Christensen examined the types of immunosuppressive medications and their varying impacts on skin cancer risk, particularly noting that certain medications like calcineurin inhibitors and azathioprine may contribute to an increased incidence. The discussion also included other immunosuppressive contexts, such as inflammatory diseases and HIV. The importance of screening and managing skin cancer risk in transplant patients was emphasized through the introduction of the Sun Track risk prediction tool, which stratifies patients according to their risk factors. Frequent follow-ups and collaboration with dermatology were recommended to optimize patient outcomes. The session concluded with encouragement for utilizing available resources and the importance of multidisciplinary approaches in managing the health of immunosuppressed populations.